Monthly News Roundup - January 2025

FDA Clears Oral Journavx, a First-in-Class, Non-Opioid Pain Treatment from Vertex Pharmaceuticals
On January 30th the FDA approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class, non-opioid analgesic to treat moderate to severe...